乙醇-维他诺化物相互作用:对斑马鱼幼虫的化合物特异性影响 机动行为和GABAA受体子单元表达GABAA受体
Kamila Czora-Poczwardowska1, Radosław Kujawski1, Weronika Jarczak1
1Department of Pharmacology, Poznan University of Medical Sciences, 60-806 Poznan, Poland.
International journal of molecular sciences
|November 27, 2025
概括
同时使用阿什瓦甘达 (Withania somnifera) 和乙醇 (EtOH) 有不同的效果. 特定的维他诺化物调节了EtOH.
科学领域:
- 神经药理学神经药理学
- 分子生物学分子生物学
- 行为神经科学 行为神经科学
背景情况:
- 同时使用Withania somnifera (WS,阿什瓦甘达) 和乙醇 (EtOH) 是常见的.
- WS化合物和EtOH之间的神经行为和分子相互作用尚未得到充分理解.
研究的目的:
- 研究三种纯化的维他诺化物 (维他诺化物A,维他,维他费林A) 如何影响斑马鱼幼虫的EtOH诱导的神经行为.
- 分析这些化合物对GABAA受体子单元基因表达的影响.
主要方法:
- 斑马鱼幼虫暴露于不同的EtOH度 (0-4.0%).
- 定量化了机动行为.
- 定量PCR (qPCR) 用于分析GABAA受体子单元的基因表达 (gabra1,gabra2,gabrd,gabrg2).
主要成果:
- EtOH诱导了双相运动反应 (刺激然后抑制).
- 维他诺利德A和维他保留/增强过活性;与维他费林A强化运动抑制.
- 维他诺化物不同调节GABAA受体亚单元mRNA表达,包括下调gabra1和gabra2.
结论:
- 个别的维他诺化物明显改变了EtOH的行为和分子效应.
- 结果表明与抑制性神经传递有特定的相互作用.
- 提供了对WS-EtOH相互作用的机制性见解.
相关概念视频
Drug-Receptor Interactions
Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue.
Dose-Response Relationship: Selectivity and Specificity
Drugs exert their therapeutic effects by interacting with receptors, enzymes, or ion channels that are present throughout the human body. The strength and duration of the interaction between a drug and its target receptor are characterized by the selectivity and specificity of the drug. Selectivity refers to a drug's strong preference for its intended target over other targets. For instance, isoprenaline, a non-selective β-adrenergic agonist, interacts with both β1- and β2-adrenergic receptors...
Drug-Receptor Interaction: Agonist
Agonists are drugs that interact with specific receptors in the body to produce a biological response. When an agonist binds to a receptor, it activates or enhances the receptor's function, leading to physiological effects. The interaction between agonist drugs and receptors is crucial for their therapeutic action in various medical treatments.
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous ligand's action.
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous ligand's action.
Neurochemical Transmission: Sites of Drug Action
Neurochemical transmission, the conduction of electrical impulses between neurons mediated by neurotransmitters, plays a vital role in various physiological processes. Autonomic drugs exert their effects by modulating neurotransmission within the autonomic nervous system. For instance, drugs such as hemicholinium block the precursor uptake necessary for synthesizing acetylcholine, an essential autonomic neurotransmitter. Following synthesis, neurotransmitters are stored in vesicles. Metyrosine...
Drugs Affecting Neurotransmitter Release or Uptake
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists
Serotonin, a crucial neurotransmitter synthesized by enterochromaffin cells, plays a cardinal role in regulating gastrointestinal (GI) motility. With over 90% of the body's total serotonin in the GI tract, its influence on digestive processes is profound. Serotonin is swiftly released upon various stimuli, such as food boluses or certain drugs, triggering intrinsic sensory neurons in the myenteric plexus and extrinsic vagal and spinal sensory neurons. This leads to the activation of the...


